Austar Lifesciences Ltd.'s total assets for Q2 2024 were ¥2.14B, a decrease of -7.18% from the previous quarter. HK:6118 total liabilities were ¥1.36B for the fiscal quarter, a -9.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.